Bare Financial Services’s Pacira BioSciences PCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.44K Hold
257
– – ﹤0.01% 807
2026
Q2
$6.52K Sell
257
-14
-5% -$331 ﹤0.01% 756
2026
Q1
$6.12K Buy
+271
New +$6.02K ﹤0.01% 558

Other funds holding PCRX

Bare Financial Services's PCRX Position: Q3 2026 in Review

Bare Financial Services held its Pacira BioSciences (PCRX) position steady in Q3 2026 at 257 shares worth $6.44K. The position accounts for ﹤0.01% of the portfolio, ranked #807.

Bare Financial Services first reported a position in PCRX in Q1 2026 and has held it in 3 quarters since. The position peaked at $6.52K in Q2 2026. 258 funds tracked by Wall St. Rank hold PCRX as of Q3 2026.

  • Bare Financial Services held 257 shares of Pacira BioSciences worth $6.44K as of Q3 2026.
  • Bare Financial Services left its Pacira BioSciences share count unchanged in Q3 2026.
  • Pacira BioSciences made up ﹤0.01% of Bare Financial Services's portfolio in Q3 2026, its #807 holding.
  • Bare Financial Services first reported a position in Pacira BioSciences in Q1 2026 and has held it in 3 quarters since.
  • Bare Financial Services's Pacira BioSciences position peaked at $6.52K in Q2 2026.
  • 258 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2026.

Based on Bare Financial Services's 13F filing for Q3 2026, filed 4 Nov 2026.